TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
0.8842
-0.0858 (-8.85%)
At close: Apr 4, 2025, 4:00 PM
0.8750
-0.0092 (-1.04%)
After-hours: Apr 4, 2025, 6:44 PM EDT

TherapeuticsMD Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-2.18-10.28112-172.42-183.52
Upgrade
Depreciation & Amortization
0.510.441.190.744.07
Upgrade
Other Amortization
----2.53
Upgrade
Asset Writedown & Restructuring Costs
1.270.48--1.13
Upgrade
Stock-Based Compensation
0.261.2711.5718.1310.68
Upgrade
Provision & Write-off of Bad Debts
----0.24
Upgrade
Other Operating Activities
-0.352.45-111.3293.838.75
Upgrade
Change in Accounts Receivable
-----8.22
Upgrade
Change in Inventory
-----3.34
Upgrade
Change in Accounts Payable
0.23-2.14-1.21-1.061.89
Upgrade
Change in Other Net Operating Assets
1.43-15.31-2.885.656.33
Upgrade
Operating Cash Flow
0.73-48.14-4.08-142.69-159.47
Upgrade
Capital Expenditures
----0.03-0.21
Upgrade
Sale (Purchase) of Intangibles
---0.36-2.19-1.39
Upgrade
Other Investing Activities
--223.83--
Upgrade
Investing Cash Flow
--223.48-2.22-1.6
Upgrade
Long-Term Debt Issued
----50
Upgrade
Long-Term Debt Repaid
---219.43-50-
Upgrade
Net Debt Issued (Repaid)
---219.43-5050
Upgrade
Issuance of Common Stock
-3.152.47184.6731.98
Upgrade
Other Financing Activities
---1.27-5.12-1.25
Upgrade
Financing Cash Flow
-3.15-235.21129.5580.73
Upgrade
Net Cash Flow
0.73-44.99-15.81-15.36-80.34
Upgrade
Free Cash Flow
0.73-48.14-4.08-142.73-159.68
Upgrade
Free Cash Flow Margin
41.57%-3697.46%-5.83%-5547.10%-246.14%
Upgrade
Free Cash Flow Per Share
0.06-4.61-0.43-17.93-28.96
Upgrade
Cash Interest Paid
--13.5525.0725.85
Upgrade
Levered Free Cash Flow
-2.99-33.8738.54-28.46-93.54
Upgrade
Unlevered Free Cash Flow
-2.99-33.8738.54-28.46-78.21
Upgrade
Change in Net Working Capital
1.5830.25-19.470.37-5.15
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q